Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries.
Nka AD, Bouba Y, Tsapi Lontsi WR, Gouissi Anguechia DH, Teto G, Ka'e AC, Semengue ENJ, Ambe Chenwi C, Takou D, Forgwei L, Tekoh TA, Ngueko AMK, Fokou BB, Efakika Gabisa J, Tchouaket MCT, TognaPabo WL, Ayuk Ngwese DT, Njiki Bikoi J, Armenia D, Colizzi V, Yotebieng M, Ndembi N, Santoro MM, Ceccherini-Silberstein F, Perno CF, Ndjolo A, Fokam J. Nka AD, et al. Viruses. 2025 Jan 6;17(1):69. doi: 10.3390/v17010069. Viruses. 2025. PMID: 39861858 Free PMC article.
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries.
Gouissi Anguechia DH, Bouba Y, Semengue ENJ, Ka'e AC, Takou D, Ambe Chenwi C, Beloumou G, Nka AD, Basseck Wome UR, Santoro MM, Ceccherini-Silberstein F, Chatté A, Montesano C, Cappelli G, Colizzi V, Ndjolo A, Mbanya D, Ndembi N, Perno CF, Fokam J. Gouissi Anguechia DH, et al. Among authors: nka ad. Viruses. 2024 Nov 29;16(12):1853. doi: 10.3390/v16121853. Viruses. 2024. PMID: 39772163 Free PMC article.
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon.
Chenwi CA, Nayang Mundo RA, Nka AD, Semengue ENJ, Beloumou GA, Ka'e AC, Togna Pabo WL, Takou D, Abba A, Djupsa SC, Molimbou E, Etame NK, Kengni Ngueko AM, Same DK, Bouba Pamen JN, Abah Abah AS, Billong SC, Ajeh Awoh R, Halle-Ekane GE, Cappelli G, Njom-Nlend AE, Zk Bissek AC, Temfack E, Santoro MM, Ceccherini-Silberstein F, Colizzi V, Kaseya J, Ndembi N, Ndjolo A, Perno CF, Fokam J. Chenwi CA, et al. Among authors: nka ad. J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241306484. doi: 10.1177/23259582241306484. J Int Assoc Provid AIDS Care. 2024. PMID: 39711049 Free PMC article.
HIV drug resistance following pre-exposure prophylaxis failure among key populations in sub-Saharan Africa: a systematic review and meta-analysis protocol.
Ngoufack Jagni Semengue E, Molimbou E, Etame NK, Ka'e CA, Ambe CC, Nka AD, Tueguem PP, Ngueko AMK, Mundo RAN, Takou D, Anoubissi JD, Akiy ZZ, Kob Ye Same DA 3rd, Ngougo DA, Billong S, Perno CF, Ndembi N, Fokam J. Ngoufack Jagni Semengue E, et al. Among authors: nka ad. Ther Adv Infect Dis. 2024 Dec 14;11:20499361241306207. doi: 10.1177/20499361241306207. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 39678994 Free PMC article.
Rates of Viral Non-Suppression and Acquired HIV-1 Drug Resistance Emergence among Children during the Sociopolitical Crisis in the Northwest Region of Cameroon: A Call for Improved Monitoring Strategies.
Ayokanmi M, Fokam J, Tchidjou HK, Chenwi CA, Hortense GK, Kamgaing N, Takou D, Beloumou GA, Semengue E, Djupsa S, Nka AD, Teto G, Dambaya B, Sosso SM, Santoro MM, Ceccherini-Silberstein F, Awoh RA, Ekane GEH, Bissek AZK, Ndembi N, Colizzi V, Mbanya D, Perno CF, Ndjolo A. Ayokanmi M, et al. Among authors: nka ad. Curr HIV Res. 2024;22(5):336-348. doi: 10.2174/011570162X319028240830064946. Curr HIV Res. 2024. PMID: 39377407
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study.
Togna Pabo WLR, Kengni Ngueko AM, Nka AD, Santoro MM, Bouba Y, Chenwi CA, Ngoufack Jagni Semengue E, Takou D, Teto G, Dambaya B, Nyasa RB, Tommo Tchouaket MC, Beloumou GA, Djupsa Ndjeyep SC, Ka'e AC, Tekoh TAK, Ayuk Ngwese DT, Etame NK, Mundo RAN, Kamgaing RS, Sosso SM, Ndip RN, Colizzi V, Cecchereni-Silberstein F, Ndjolo A, Fokam J. Togna Pabo WLR, et al. Among authors: nka ad. Front Med (Lausanne). 2024 Sep 20;11:1457501. doi: 10.3389/fmed.2024.1457501. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39371336 Free PMC article.
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study.
Fokam J, Bouba Y, Ajeh RA, Guebiapsi DT, Essamba S, Zeh Meka AF, Lifanda E, Ada RA, Yakouba L, Mbengono NB, Djomo ARD, Tetang SN, Sosso SM, Babodo JC, Ambomo OFN, Temgoua EM, Medouane C, Atsinkou SN, Mvogo JL, Onana RM, Anoubissi JD, Ketchaji A, Nka AD, Gouissi DA, Ka'e AC, Fainguem NN, Kamgaing RS, Takou D, Tchouaket MCT, Semengue ENJ, Atsama MA, Nwobegahay J, Vuchas C, Nsimen AN, Bille BE, Gatchuessi SK, Ateba FN, Kesseng D, Billong SC, Armenia D, Santoro MM, Ceccherini-Silberstein F, Koki PN, Hamsatou HC, Colizzi V, Ndjolo A, Perno CF, Zoung-Kanyi Bissek AC. Fokam J, et al. Among authors: nka ad. Biomedicines. 2024 Sep 12;12(9):2083. doi: 10.3390/biomedicines12092083. Biomedicines. 2024. PMID: 39335597 Free PMC article.
HIV-1 residual risk and pre-treatment drug resistance among blood donors: A sentinel surveillance from Gabon.
Mangala C, Takou D, Maulot-Bangola D, Beloumou G, Rebienot Pellegrin O, Sosso SM, Ambe Chenwi C, Ngoufack Jagni Semengue E, Vigan Codjo F, Boussougou O, Nka AD, Tommo M, Fainguem N, Kamgaing R, Ama Moor V, Kamga Gonsu H, Penlap V, Nkoa T, Colizzi V, Perno CF, Fokam J, Ndjolo A. Mangala C, et al. Among authors: nka ad. PLoS One. 2024 Sep 3;19(9):e0305935. doi: 10.1371/journal.pone.0305935. eCollection 2024. PLoS One. 2024. PMID: 39226273 Free PMC article.
XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 Wavelets with flu-like symptoms in Cameroon: A snapshot from genomic surveillance.
Fokam J, Ngoufack Jagni Semengue E, Gouissi Anguechia DH, Etame NK, Takou D, Mandeng N, Kengni Ngueko MA, Beloumou Angong G, Djupsa Ndjeyep S, Chenwi Ambe C, Nka AD, Molimbou E, Mundo Nayang AR, Moko Fotso LG, Tambe Ayuk Ngwese D, Tueguem PP, Tommo Tchouaket CM, Ka'e AC, Fainguem N, Abega Abega C, Halle-Ekane EG, Esso L, Etoundi Mballa AG, Shang J, Ndongmo CB, Cappelli G, Kifle Tessema S, Z-K Bissek AC, Colizzi V, Ndjolo A, Perno CF, Ndembi N. Fokam J, et al. Among authors: nka ad. PLOS Glob Public Health. 2024 May 10;4(5):e0003153. doi: 10.1371/journal.pgph.0003153. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38728356 Free PMC article.
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon.
Fokam J, Gouissi Anguechia DH, Takou D, Jagni Semengue EN, Chenwi C, Beloumou G, Djupsa S, Nka AD, Togna Pabo WLR, Abba A, Ka'e AC, Kengni A, Etame NK, Moko LG, Molimbou E, Nayang Mundo RA, Tommo M, Fainguem N, Fotsing LM, Colagrossi L, Alteri C, Ngono D, Otshudiema JO, Ndongmo C, Boum Y, Etoundi GM, Halle EGE, Eben-Moussi E, Montesano C, Marcelin AG, Colizzi V, Perno CF, Ndjolo A, Ndembi N. Fokam J, et al. Among authors: nka ad. Heliyon. 2024 Apr 6;10(7):e29243. doi: 10.1016/j.heliyon.2024.e29243. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38623229 Free PMC article.
48 results